NPI registry status
Active
2026 NPPES data Dermatology Physician NPI 1164620670 MD
Verify on CMS → Kara Lefevre, MD
Dermatology Physician in Columbia, Missouri.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 14,645 in Dermatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
267
Medicare Part D claims · 76 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
60%
generic claims · 40% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.1 · Exceptional
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Kara Lefevre, MD reported a CMS MIPS final score of 100/100 - above the 83.1 national average - and filed 267 Medicare Part D claims in 2023.
- 100/100
- MIPS score · +17 vs avg
- 267
- Part D claims, 2023
- 60%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Kara Lefevre, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
100 Top 7% higher than 93% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Kara Lefevre, MD sits
This provider among dermatology physician peers
Across the 6,594 dermatology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Kara Lefevre, MD writes more Part D claims than 16% of them and scores higher on MIPS quality than 87% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one dermatology physician peer from a representative sample of 60; the gold marker is Kara Lefevre, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Kara Lefevre, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Kara Lefevre, MD?
High performer (top quartile)Primary specialty
Dermatology Physician
Medicare Part D claims
267 63% vs specialty avg
MIPS final score
100/100 16.9 pts vs avg
Specialty distribution in Missouri
How Dermatology Physician compares to other specialties among Missouri providers
Medicare quality performance, MIPS
Kara Lefevre, MD's 2023 MIPS final score plotted against the Dermatology Physician national average
- MIPS Final Score
- 100/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Dermatology Physician) - 100/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Kara Lefevre, MD appears in the CMS NPPES registry as a Dermatology Physician provider holding MD credentials at 4230 PHILIPS FARM RD, Columbia, MO, 65201, with a listed phone of (573) 882-4800. NPI 1164620670 was issued on 07/05/2007.
Medicare Part D records for calendar year 2023 show 267 prescription claims written by this provider, covering 76 Medicare beneficiaries and totaling roughly $891K in drug spend, split 40% brand-name and 60% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year, compared with the national average of 83.1.
Dermatology Physician is a mid-sized specialty nationwide, with 14,645 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1164620670 |
|---|---|
| Specialty | Dermatology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 07/05/2007 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
100
Final Score
Avg: 83.1
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Kara Lefevre, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
The Curators OF The University OF Missouri
Columbia, MO
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Above average
Kara Lefevre, MD - brand share 40.0%
Dermatology Physician average
40% brand-name claims vs 60% generic, on 267 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
267
Total Claims
$891K
Total Drug Cost
76
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 409
- Total Day Supply
- 11,741
- Brand vs Generic
- 40% brand / 60% generic
- Brand Drug Cost
- $881K
- Generic Drug Cost
- $10K
- Antibiotic Claims
- 11
Patient Demographics
- Average Patient Age
- 63.2 years
- Avg HCC Risk Score
- 1.53
- Gender Split
- 66% female / 34% male
- Age Distribution
- <65: 36, 65-74: 21, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Kara Lefevre, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Triamcinolone Acet…
Triamcinolone Acetonide
18 claims
- Clobetasol Propion…
Clobetasol Propionate
17 claims
- Dupixent Pen
Dupixent Pen
16 claims
- Betamethasone Vale…
Betamethasone Valerate
15 claims
- Hydroxychloroquine…
Hydroxychloroquine Sulfate
15 claims
- Tretinoin
Tretinoin
13 claims
- Cosentyx Sensoread…
Cosentyx Sensoready (2 Pens)
11 claims
- Doxepin Hcl
Doxepin Hcl
11 claims
| Drug | Claims |
|---|---|
| Triamcinolone Acetonide | 18 |
| Clobetasol Propionate | 17 |
| Dupixent Pen Dupilumab | 16 |
| Betamethasone Valerate | 15 |
| Hydroxychloroquine Sulfate | 15 |
| Tretinoin | 13 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 11 |
| Doxepin Hcl | 11 |
| Humira(Cf) Pen Adalimumab | 11 |
| Spironolactone | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Dermatology Physician Overview
How Kara Lefevre, MD fits within the Dermatology Physician landscape nationally.
14,645
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider
Kara Lefevre, MD's 267 claims are below the specialty average of 729.
Nearby Dermatology Physician Providers in Missouri
Other clinicians with the same primary specialty enrolled in Missouri, drawn from the same CMS NPPES roster as Lefevre.
Dr. Mallory Abate
M.D.
Saint Louis, MO
Dr. Benjamin Adams
D.O.
Kirksville, MO
Anna Aiazzi
Saint Louis, MO
Dr. Osaigbokan Aihie
MD
Columbia, MO
Dr. Susan Ailor
MD
Columbia, MO
Compare Dermatology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Missouri medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Dermatology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Missouri
Frequently Asked Questions
What is Kara Lefevre, MD's specialty? ▼
Kara Lefevre, MD specializes in Dermatology Physician and practices in Columbia, Missouri. Credentials: MD.
How much does Kara Lefevre, MD prescribe under Medicare Part D? ▼
In 2023, Kara Lefevre, MD wrote 267 Medicare Part D claims totaling $891K in drug costs for 76 beneficiaries.
What is Kara Lefevre, MD's Medicare quality score? ▼
Kara Lefevre, MD has a CMS MIPS Final Score of 100/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Kara Lefevre, MD located? ▼
Kara Lefevre, MD is located at 4230 PHILIPS FARM RD, Columbia, MO, 65201. Phone: (573) 882-4800.
What is Kara Lefevre, MD's NPI number? ▼
Kara Lefevre, MD's National Provider Identifier (NPI) is 1164620670, issued on 07/05/2007.
Does Kara Lefevre, MD prescribe more brand-name or generic drugs? ▼
Kara Lefevre, MD's prescribing is 40% brand-name and 60% generic drugs by claim count, with $881K in brand drug costs.
How many Dermatology Physician providers are there in the US? ▼
There are 14,645 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does Kara Lefevre, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Kara Lefevre, MD's most frequently prescribed drugs include Triamcinolone Acetonide, Clobetasol Propionate, Dupixent Pen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Kara Lefevre, MD accept Medicare? ▼
Kara Lefevre, MD appears in CMS Medicare data with 267 Part D claims and 76 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Kara Lefevre, MD's credentials? ▼
Kara Lefevre, MD's NPI is 1164620670 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.